Starling Oncology, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2020 | — | $-87.8K | $-776.8K |
| Jun 2020 | — | $-194.6K | $-2.6M |
| Sep 2020 | — | $-198.5K | $-2.4M |
| Mar 2021 | $48.6M | $-1.8M | $-996.0K |
| Jun 2021 | $49.8M | $-1.1M | $3.2M |
| Sep 2021 | $52.3M | $-2.2M | $-3.0M |
| Mar 2022 | $55.2M | $-18.5M | $19.3M |
| Jun 2022 | $60.9M | $-18.3M | $-5.5M |
| Sep 2022 | $65.0M | $-20.1M | $-2.7M |
| Mar 2023 | $76.2M | $-32.9M | $-30.0M |
| Jun 2023 | $80.2M | $-14.9M | $-16.9M |
| Sep 2023 | $82.0M | $-13.9M | $-17.4M |
| Mar 2024 | $94.7M | $-18.0M | $-19.9M |
| Jun 2024 | $98.6M | $-16.4M | $-15.5M |
| Sep 2024 | $99.9M | $-13.9M | $-16.1M |
| Mar 2025 | $104.4M | $-9.9M | $-19.6M |
| Jun 2025 | $119.8M | $-11.2M | $-17.0M |
| Sep 2025 | $136.6M | $-8.1M | $-16.5M |
| Mar 2026 | $147.4M | $-6.5M | $-2.5M |
| Jun 2026 | $161.3M | $-4.6M | $-9.8M |